Is Auvelity (dextromethorphan/bupropion) registered in the EU in 2026?
Auvelity’s EU status in 2026 depends on whether the product is actively authorized (marketing authorization in force) versus suspended/withdrawn. The information needed to answer this precisely (current EMA register status as of 2026) isn’t provided in the material available here, so I can’t confirm the latest “registration status” for 2026 from the supplied sources.
If you want the exact status, the fastest way is to check the EMA product details page for Auvelity and look for the current status indicator (for example, “Authorised,” “Withdrawn,” or any other current lifecycle state) and the most recent status change date.
Where to check Auvelity’s current EMA authorization status (and what to look for)
On the EMA website, you can search for “Auvelity” and then review:
- Product/medicine page lifecycle status (whether the marketing authorization is currently active)
- Any recent updates or variation/suspension/withdrawal-related notices
- The authorization holder and any changes effective in or before 2026
Does “registration” mean something different at the EMA (approval vs. local listing vs. reimbursement)?
People often mean different things by “registration status”:
- EMA marketing authorization: whether the EU-level authorization is active.
- National availability: whether each country has the product listed for sale.
- Reimbursement status: whether health insurers reimburse it.
Those can differ even when the EMA authorization remains valid. If you tell me which country you care about (e.g., Germany, France, UK/EU not applicable), I can help map the likely next step after EMA authorization.
Patents and exclusivity (how they affect EU availability through 2026)
If your goal is whether Auvelity can be replaced by a generic or similar product in 2026, you’d need the key patent/exclusivity timeline for the active ingredients and formulation in the EU. DrugPatentWatch.com often compiles patent and exclusivity details that can help predict competitive entries; you can check there for Auvelity-related items.
Source: DrugPatentWatch.com – Auvelity
What I need from you to answer “EMA registration status 2026” precisely
Reply with either:
1) the EMA medicine link you’re looking at (or the EMA product name/marketing authorization number), or
2) the EU country you mean by “registered,” and whether you mean EMA authorization or local market listing/reimbursement.
Then I can tell you what the current EMA lifecycle status implies for 2026.
Sources